10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 10:45 a.m. Eastern Time.
加利福尼亞州普萊森頓，2024年8月22日/美通社/ - 10x genomics, Inc.（納斯達克：TXG），單細胞和空間生物學領域的領先者，今天宣佈其管理團隊成員將於9月4日星期三上午10點45分參加摩根士丹利公司第22屆全球醫療保健年會的爐邊聊天。
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: . The webcast will be archived and available for replay for at least 45 days after the event.
有興趣的人可以在公司網站的「投資者」部分實時觀看爐邊聊天的網絡直播：。網絡直播將被存檔，並在活動結束後至少45天內提供重播。
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
10x Genomics是一家生命科學技術公司，致力於打造能夠加速生物學掌握和促進人體健康的產品。我們的綜合解決方案包括單細胞和空間生物學的儀器、消耗品和軟件，幫助學術和轉化研究人員以及生物製藥公司以與生物學複雜性相匹配的分辨率和尺度理解生物系統。我們的產品在腫瘤學、免疫學、神經科學等方面取得了突破性進展，推動了深入理解健康和疾病的強大發現。如欲了解更多信息，敬請訪問10xgenomics.com。
來源10x Genomics，Inc。10xgenomics.com「或在上述渠道與我們聯繫」
LinkedIn或。X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
披露信息
10x Genomics使用證券交易委員會的申報文件、我們的網站(10xgenomics.com)、新聞稿、公共電話會議、公共網絡廣播和我們的社交媒體帳戶作爲披露非公開信息和遵守我們根據FD條例的披露義務的手段。），新聞稿，公共電話會議，公共網絡廣播和我們的社交媒體帳戶作爲披露重要的非公共信息和遵守我們根據FD條例的披露義務的手段。
Contacts
Investors: [email protected]
Media: [email protected]
聯繫方式
投資者：[email protected]
媒體:[email protected]
SOURCE 10x Genomics, Inc.
來源：10x Genomics, Inc。
譯文內容由第三人軟體翻譯。